Global Therapeutic Vaccines Market Analysis & Opportunity Outlook 2021

Therapeutic Vaccines are the vaccines that give immunity to the body to act against various infectious diseases such as: HIV, Cancer, Hepatitis C, Neurological Disease, Parkinson’s disease, Alzheimer's disease and other infectious diseases. Growing at a CAGR of 33.8%, the global market of therapeutic vaccines is anticipated to reach USD 4.84 Billion over the forecasted period from 2015-2021.

Market Segmentation

By Vaccine Types

• Infectious Disease Vaccines
• Addiction Vaccines
• Neurological disease vaccines
• Autoimmune Disease Vaccines

By Geography

The global market of Therapeutic Vaccines can be segmented into these categories:

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific
• Rest Of The World

By Technologies

• Allogeneic vaccines
• Autologous vaccines

Growth Drivers and Challenges

Escalating chronic diseases, expanded government funds for the vaccines development, great penetration of healthcare insurance in almost every country across the globe, rising medical tourism especially in Asia etc. are few of the key drivers for the global market of therapeutic vaccines.

However, high cost of vaccines, generic drugs usage in developing countries and complex policies made by the government are projected to hamper the growth of global market of therapeutic vaccines.

Market size and forecast

At present, North America is the biggest market for therapeutic vaccine and expected to continue its dominance in near future. The North America market was estimated USD 79,283 Million in 2014 which is projected to reach USD 147,801 Million by 2021.

Asia-Pacific Region is anticipated to grow at a high rate owning to increase in aging population over the forecasted years.

Key Players

• Cytos Biotechnology
• Antigenics
• Bavarian Nordic
• Celldex Therapeutics
• Affiris
• Argos Therapeutics
• Biovest International
• Celtic Pharma
• Cel-Sci
• Curevac